Is Routine Postoperative Oxygen Therapy Still Necessary in 2020?

NCT ID: NCT05009628

Last Updated: 2022-01-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-07-05

Study Completion Date

2021-11-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study by automated control of oxygen supply in the immediate postoperative period is to show the possibility of immediate weaning in the postoperative period in case of remifentanil use and complete reversion of curarization.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The main hypothesis of this study is that classical oxygen therapy at 3l/min is futile in the postoperative period of a so-called modern anaesthesia and that a total weaning within one hour after arrival in the ICU is possible whatever the postoperative position of the patient. The aim is therefore to include patients who have to undergo a scheduled surgery under anaesthetic sedation (analgesia with remifentanil) or general anaesthesia (combining remifentanil, propofol rocuronium) for ambulatory surgery. The trial is interventional, randomized, monocentric to demonstrate the absence of interest of prolonged postoperative oxygen therapy under specific intraoperative conditions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Oxygen Therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

interventional study with 4 paralel arms ; randomization is realised according to a centralized and balanced 2x2 factorial design
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

automated oxygenation with a sitting patient position in the ICU

Group Type EXPERIMENTAL

automated oxygenation with a sitting patient position in the ICU

Intervention Type PROCEDURE

Oxygenation will be done with the Free O2 device via oxygen goggles or a face mask and with an O2 prescription to obtain a SpO2\> 94%. The patient's position in the ICU will be a sitting position with the chest raised at an angle greater than 45°.

controlled oxygenation with a lying patient position in the ICU

Group Type NO_INTERVENTION

No interventions assigned to this group

automated oxygenation with the patient lying down in the ICU

Group Type EXPERIMENTAL

Automated oxygenation with the patient lying down in the ICU

Intervention Type PROCEDURE

Oxygenation will be done with the Free O2 device via oxygen goggles or a face mask and with an O2 prescription to obtain a SpO2\> 94%. The patient's position in the ICU will be a recumbent position with the head elevated to a maximum of 10

control oxygenation with the patient in a sitting position in the ICU

Group Type EXPERIMENTAL

Oxygenation is controlled with the patient in a sitting position in the ICU.

Intervention Type PROCEDURE

ICU. Oxygenation will be done via the same interface in manual mode where the post-interventional monitoring room nurse modifies the flow to maintain oxygen saturation above 94%. The patient's position in the ICU will be a sitting position with the chest raised at an angle greater than 45°.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

automated oxygenation with a sitting patient position in the ICU

Oxygenation will be done with the Free O2 device via oxygen goggles or a face mask and with an O2 prescription to obtain a SpO2\> 94%. The patient's position in the ICU will be a sitting position with the chest raised at an angle greater than 45°.

Intervention Type PROCEDURE

Automated oxygenation with the patient lying down in the ICU

Oxygenation will be done with the Free O2 device via oxygen goggles or a face mask and with an O2 prescription to obtain a SpO2\> 94%. The patient's position in the ICU will be a recumbent position with the head elevated to a maximum of 10

Intervention Type PROCEDURE

Oxygenation is controlled with the patient in a sitting position in the ICU.

ICU. Oxygenation will be done via the same interface in manual mode where the post-interventional monitoring room nurse modifies the flow to maintain oxygen saturation above 94%. The patient's position in the ICU will be a sitting position with the chest raised at an angle greater than 45°.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients managed by the Anesthesia Department of the Foch Hospital;
* Anesthetic sedation (analgesia with remifentanil) or general anesthesia (combining remifentanil, propofol and possibly rocuronium);
* Men or women over 18 and under 80 years of age;
* To benefit from a surgical intervention scheduled \> 48 hours in relation to the procedure;
* Scheduled outpatient surgery;
* Have signed a consent form;
* Be affiliated to a health insurance plan.

Exclusion Criteria

* Pregnant or nursing patients;
* Oxygen dependent preoperatively or at risk of oxygen dependence postoperatively;
* Lung resection surgery;
* Brain surgery (intracerebral neurosurgery); ENT surgery requiring a half-seated position after the operation;
* Being deprived of liberty or under guardianship.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hopital Foch

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Foch

Suresnes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019_0006

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Perioperative UtiLisation of SupplEmental Oxygen
NCT03552627 ACTIVE_NOT_RECRUITING PHASE4